American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
CSL LTD
$17.08
-0.23%
OTC: CSLLY · 15-min delayed
CSLLYOTC
1994Founded
About CSL LTD
CSL LTD SP/ADR
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
OTC: CSLLY
$17.08
-0.23%
15-minute delayed · data by Polygon.io
Past year
$16.35
$44.49
52-week range
- Dividend yield
- 3.74%
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Market data by Polygon.io · prices are 15-minute delayed
Auto-generated
At a glance
- Trading 62% below its 52-week high.
- Pays a dividend yielding about 3.74% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review CSL LTD.
Write a review
Newsroom
News about CSL LTD
CSL announces expansion of Illinois plasma therapy manufacturing facility
Canada and CSL Seqirus, a Global Leader in Influenza Vaccines, agree on new Pandemic Preparedness Contract
Eli Lilly's Landmark Trial Shows Major Psoriasis-Obesity Breakthrough With Taltz-Zepbound Combo
Global Fibrin Sealant Market Size to Reach USD 3.57 Billion by 2035 with 8.37% CAGR – SNS Insider
VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization
Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years
News & sentiment via Polygon.io
Explore
Browse all →
